Einfluss adjuvanter Therapien des initial hormonrezeptorpositiven Mammakarzinoms auf die Entwicklung einer Rezeptorkonversion im Rezidiv: = Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Abschlussarbeit Buch |
| Sprache: | German |
| Veröffentlicht: |
Würzburg
Mai 2020
|
| Schlagworte: | |
| Online-Zugang: | kostenfrei |
| Beschreibung: | erschienen 2021 |
| Beschreibung: | 72 Seiten Diagramme |
| DOI: | 10.25972/OPUS-22181 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV047210162 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 210323s2020 gw |||| m||| 00||| ger d | ||
| 015 | |a 21,O03 |2 dnb | ||
| 035 | |a (OCoLC)1245337225 | ||
| 035 | |a (DE-599)BVBBV047210162 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |8 3\p |a ger | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-384 |a DE-473 |a DE-703 |a DE-1051 |a DE-824 |a DE-29 |a DE-12 |a DE-91 |a DE-19 |a DE-1049 |a DE-92 |a DE-739 |a DE-898 |a DE-355 |a DE-706 |a DE-20 |a DE-1102 |a DE-860 |a DE-2174 | ||
| 084 | |8 2\p |a 610 |2 23sdnb | ||
| 084 | |8 1\p |a 616.994 |2 23ksdnb | ||
| 100 | 1 | |a Weiß, Claire Rachel |d 1988- |e Verfasser |0 (DE-588)1229965351 |4 aut | |
| 245 | 1 | 0 | |a Einfluss adjuvanter Therapien des initial hormonrezeptorpositiven Mammakarzinoms auf die Entwicklung einer Rezeptorkonversion im Rezidiv |b = Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer |c vorgelegt von Claire Rachel Weiß aus Berlin |
| 246 | 1 | 1 | |a Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer |
| 264 | 1 | |a Würzburg |c Mai 2020 | |
| 300 | |a 72 Seiten |b Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a erschienen 2021 | ||
| 502 | |b Dissertation |c Julius-Maximilians-Universität Würzburg |d 2020 | ||
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |5 DE-101 |2 pdager | |
| 650 | 0 | 7 | |8 4\p |a Brustkrebs |0 (DE-588)4008528-4 |2 gnd |
| 650 | 0 | 7 | |8 5\p |a Rezidiv |0 (DE-588)4130100-6 |2 gnd |
| 650 | 0 | 7 | |8 6\p |a Rezeptor |0 (DE-588)4049722-7 |2 gnd |
| 650 | 0 | 7 | |8 7\p |a Therapie |0 (DE-588)4059798-2 |2 gnd |
| 650 | 0 | 7 | |8 8\p |a Adjuvante Therapie |0 (DE-588)4218974-3 |2 gnd |
| 650 | 0 | 7 | |8 9\p |a Endokrinotherapie |0 (DE-588)4195787-8 |2 gnd |
| 653 | |a Mammakarzinom | ||
| 653 | |a Therapie | ||
| 653 | |a Rezeptorkonversion | ||
| 653 | |a Rezidiv | ||
| 653 | |a Breast cancer | ||
| 653 | |a therapy | ||
| 653 | |a recurrent | ||
| 653 | |a receptor conversion | ||
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |o urn:nbn:de:bvb:20-opus-221814 |o doi:10.25972/OPUS-22181 |
| 856 | 4 | 1 | |u https://doi.org/10.25972/OPUS-22181 |x Resolving-System |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032614983 | ||
| 883 | 0 | |8 1\p |a aepkn |c 0,99999 |d 20210209 |q DE-101 |u https://d-nb.info/provenance/plan#aepkn | |
| 883 | 0 | |8 2\p |a aepsg |c 1,00000 |d 20210209 |q DE-101 |u https://d-nb.info/provenance/plan#aepsg | |
| 883 | 1 | |8 3\p |a npi |d 20210208 |q DE-101 |u https://d-nb.info/provenance/plan#npi | |
| 883 | 0 | |8 4\p |a aepgnd |c 0,32728 |d 20210209 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
| 883 | 0 | |8 5\p |a aepgnd |c 0,18486 |d 20210209 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
| 883 | 0 | |8 6\p |a aepgnd |c 0,18329 |d 20210209 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
| 883 | 0 | |8 7\p |a aepgnd |c 0,16446 |d 20210209 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
| 883 | 0 | |8 8\p |a aepgnd |c 0,06328 |d 20210209 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
| 883 | 0 | |8 9\p |a aepgnd |c 0,05586 |d 20210209 |q DE-101 |u https://d-nb.info/provenance/plan#aepgnd | |
Datensatz im Suchindex
| _version_ | 1804182323570147328 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Weiß, Claire Rachel 1988- |
| author_GND | (DE-588)1229965351 |
| author_facet | Weiß, Claire Rachel 1988- |
| author_role | aut |
| author_sort | Weiß, Claire Rachel 1988- |
| author_variant | c r w cr crw |
| building | Verbundindex |
| bvnumber | BV047210162 |
| collection | ebook |
| ctrlnum | (OCoLC)1245337225 (DE-599)BVBBV047210162 |
| doi_str_mv | 10.25972/OPUS-22181 |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03263nam a2200661zc 4500</leader><controlfield tag="001">BV047210162</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">210323s2020 gw |||| m||| 00||| ger d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">21,O03</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1245337225</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047210162</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">ger</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-384</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-1051</subfield><subfield code="a">DE-824</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-1049</subfield><subfield code="a">DE-92</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-898</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-706</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-1102</subfield><subfield code="a">DE-860</subfield><subfield code="a">DE-2174</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">2\p</subfield><subfield code="a">610</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">616.994</subfield><subfield code="2">23ksdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Weiß, Claire Rachel</subfield><subfield code="d">1988-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1229965351</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Einfluss adjuvanter Therapien des initial hormonrezeptorpositiven Mammakarzinoms auf die Entwicklung einer Rezeptorkonversion im Rezidiv</subfield><subfield code="b">= Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer</subfield><subfield code="c">vorgelegt von Claire Rachel Weiß aus Berlin</subfield></datafield><datafield tag="246" ind1="1" ind2="1"><subfield code="a">Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Würzburg</subfield><subfield code="c">Mai 2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">72 Seiten</subfield><subfield code="b">Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">erschienen 2021</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Julius-Maximilians-Universität Würzburg</subfield><subfield code="d">2020</subfield></datafield><datafield tag="583" ind1="1" ind2=" "><subfield code="a">Archivierung/Langzeitarchivierung gewährleistet</subfield><subfield code="5">DE-101</subfield><subfield code="2">pdager</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">4\p</subfield><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">5\p</subfield><subfield code="a">Rezidiv</subfield><subfield code="0">(DE-588)4130100-6</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">6\p</subfield><subfield code="a">Rezeptor</subfield><subfield code="0">(DE-588)4049722-7</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">7\p</subfield><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">8\p</subfield><subfield code="a">Adjuvante Therapie</subfield><subfield code="0">(DE-588)4218974-3</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="8">9\p</subfield><subfield code="a">Endokrinotherapie</subfield><subfield code="0">(DE-588)4195787-8</subfield><subfield code="2">gnd</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Mammakarzinom</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Therapie</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Rezeptorkonversion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Rezidiv</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Breast cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">recurrent</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">receptor conversion</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="o">urn:nbn:de:bvb:20-opus-221814</subfield><subfield code="o">doi:10.25972/OPUS-22181</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">https://doi.org/10.25972/OPUS-22181</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032614983</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">aepkn</subfield><subfield code="c">0,99999</subfield><subfield code="d">20210209</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepkn</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">aepsg</subfield><subfield code="c">1,00000</subfield><subfield code="d">20210209</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepsg</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">npi</subfield><subfield code="d">20210208</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#npi</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,32728</subfield><subfield code="d">20210209</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">5\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,18486</subfield><subfield code="d">20210209</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">6\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,18329</subfield><subfield code="d">20210209</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">7\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,16446</subfield><subfield code="d">20210209</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">8\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,06328</subfield><subfield code="d">20210209</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">9\p</subfield><subfield code="a">aepgnd</subfield><subfield code="c">0,05586</subfield><subfield code="d">20210209</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#aepgnd</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV047210162 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T16:54:05Z |
| indexdate | 2024-07-10T09:05:44Z |
| institution | BVB |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032614983 |
| oclc_num | 1245337225 |
| open_access_boolean | 1 |
| owner | DE-384 DE-473 DE-BY-UBG DE-703 DE-1051 DE-824 DE-29 DE-12 DE-91 DE-BY-TUM DE-19 DE-BY-UBM DE-1049 DE-92 DE-739 DE-898 DE-BY-UBR DE-355 DE-BY-UBR DE-706 DE-20 DE-1102 DE-860 DE-2174 |
| owner_facet | DE-384 DE-473 DE-BY-UBG DE-703 DE-1051 DE-824 DE-29 DE-12 DE-91 DE-BY-TUM DE-19 DE-BY-UBM DE-1049 DE-92 DE-739 DE-898 DE-BY-UBR DE-355 DE-BY-UBR DE-706 DE-20 DE-1102 DE-860 DE-2174 |
| physical | 72 Seiten Diagramme |
| psigel | ebook |
| publishDate | 2020 |
| publishDateSearch | 2020 |
| publishDateSort | 2020 |
| record_format | marc |
| spelling | Weiß, Claire Rachel 1988- Verfasser (DE-588)1229965351 aut Einfluss adjuvanter Therapien des initial hormonrezeptorpositiven Mammakarzinoms auf die Entwicklung einer Rezeptorkonversion im Rezidiv = Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer vorgelegt von Claire Rachel Weiß aus Berlin Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer Würzburg Mai 2020 72 Seiten Diagramme txt rdacontent n rdamedia nc rdacarrier erschienen 2021 Dissertation Julius-Maximilians-Universität Würzburg 2020 Archivierung/Langzeitarchivierung gewährleistet DE-101 pdager 4\p Brustkrebs (DE-588)4008528-4 gnd 5\p Rezidiv (DE-588)4130100-6 gnd 6\p Rezeptor (DE-588)4049722-7 gnd 7\p Therapie (DE-588)4059798-2 gnd 8\p Adjuvante Therapie (DE-588)4218974-3 gnd 9\p Endokrinotherapie (DE-588)4195787-8 gnd Mammakarzinom Therapie Rezeptorkonversion Rezidiv Breast cancer therapy recurrent receptor conversion (DE-588)4113937-9 Hochschulschrift gnd-content Erscheint auch als Online-Ausgabe urn:nbn:de:bvb:20-opus-221814 doi:10.25972/OPUS-22181 https://doi.org/10.25972/OPUS-22181 Resolving-System kostenfrei Volltext 1\p aepkn 0,99999 20210209 DE-101 https://d-nb.info/provenance/plan#aepkn 2\p aepsg 1,00000 20210209 DE-101 https://d-nb.info/provenance/plan#aepsg 3\p npi 20210208 DE-101 https://d-nb.info/provenance/plan#npi 4\p aepgnd 0,32728 20210209 DE-101 https://d-nb.info/provenance/plan#aepgnd 5\p aepgnd 0,18486 20210209 DE-101 https://d-nb.info/provenance/plan#aepgnd 6\p aepgnd 0,18329 20210209 DE-101 https://d-nb.info/provenance/plan#aepgnd 7\p aepgnd 0,16446 20210209 DE-101 https://d-nb.info/provenance/plan#aepgnd 8\p aepgnd 0,06328 20210209 DE-101 https://d-nb.info/provenance/plan#aepgnd 9\p aepgnd 0,05586 20210209 DE-101 https://d-nb.info/provenance/plan#aepgnd |
| spellingShingle | Weiß, Claire Rachel 1988- Einfluss adjuvanter Therapien des initial hormonrezeptorpositiven Mammakarzinoms auf die Entwicklung einer Rezeptorkonversion im Rezidiv = Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer 4\p Brustkrebs (DE-588)4008528-4 gnd 5\p Rezidiv (DE-588)4130100-6 gnd 6\p Rezeptor (DE-588)4049722-7 gnd 7\p Therapie (DE-588)4059798-2 gnd 8\p Adjuvante Therapie (DE-588)4218974-3 gnd 9\p Endokrinotherapie (DE-588)4195787-8 gnd |
| subject_GND | (DE-588)4008528-4 (DE-588)4130100-6 (DE-588)4049722-7 (DE-588)4059798-2 (DE-588)4218974-3 (DE-588)4195787-8 (DE-588)4113937-9 |
| title | Einfluss adjuvanter Therapien des initial hormonrezeptorpositiven Mammakarzinoms auf die Entwicklung einer Rezeptorkonversion im Rezidiv = Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer |
| title_alt | Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer |
| title_auth | Einfluss adjuvanter Therapien des initial hormonrezeptorpositiven Mammakarzinoms auf die Entwicklung einer Rezeptorkonversion im Rezidiv = Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer |
| title_exact_search | Einfluss adjuvanter Therapien des initial hormonrezeptorpositiven Mammakarzinoms auf die Entwicklung einer Rezeptorkonversion im Rezidiv = Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer |
| title_exact_search_txtP | Einfluss adjuvanter Therapien des initial hormonrezeptorpositiven Mammakarzinoms auf die Entwicklung einer Rezeptorkonversion im Rezidiv = Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer |
| title_full | Einfluss adjuvanter Therapien des initial hormonrezeptorpositiven Mammakarzinoms auf die Entwicklung einer Rezeptorkonversion im Rezidiv = Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer vorgelegt von Claire Rachel Weiß aus Berlin |
| title_fullStr | Einfluss adjuvanter Therapien des initial hormonrezeptorpositiven Mammakarzinoms auf die Entwicklung einer Rezeptorkonversion im Rezidiv = Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer vorgelegt von Claire Rachel Weiß aus Berlin |
| title_full_unstemmed | Einfluss adjuvanter Therapien des initial hormonrezeptorpositiven Mammakarzinoms auf die Entwicklung einer Rezeptorkonversion im Rezidiv = Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer vorgelegt von Claire Rachel Weiß aus Berlin |
| title_short | Einfluss adjuvanter Therapien des initial hormonrezeptorpositiven Mammakarzinoms auf die Entwicklung einer Rezeptorkonversion im Rezidiv |
| title_sort | einfluss adjuvanter therapien des initial hormonrezeptorpositiven mammakarzinoms auf die entwicklung einer rezeptorkonversion im rezidiv influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer |
| title_sub | = Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer |
| topic | 4\p Brustkrebs (DE-588)4008528-4 gnd 5\p Rezidiv (DE-588)4130100-6 gnd 6\p Rezeptor (DE-588)4049722-7 gnd 7\p Therapie (DE-588)4059798-2 gnd 8\p Adjuvante Therapie (DE-588)4218974-3 gnd 9\p Endokrinotherapie (DE-588)4195787-8 gnd |
| topic_facet | Brustkrebs Rezidiv Rezeptor Therapie Adjuvante Therapie Endokrinotherapie Hochschulschrift |
| url | https://doi.org/10.25972/OPUS-22181 |
| work_keys_str_mv | AT weißclairerachel einflussadjuvantertherapiendesinitialhormonrezeptorpositivenmammakarzinomsaufdieentwicklungeinerrezeptorkonversionimrezidivinfluencesofadjuvanttreatmentsinhormonereceptorpositivebreastcanceronreceptorconversioninrecurrentbreastcancer AT weißclairerachel influencesofadjuvanttreatmentsinhormonereceptorpositivebreastcanceronreceptorconversioninrecurrentbreastcancer |